Evaluation of Negative Pressure Wound Therapy in the Treatment of DFUs Incl. Post Amputation Wounds.

March 20, 2012 updated by: Molnlycke Health Care AB

A Prospective, Open, Non-controlled Clinical Investigation to Evaluate a NPWT (Negative Pressure Wound Therapy) System to be Used in the Treatment of Diabetic Foot Ulcers (DFUs) Including Post Amputation Wounds Associated With Diabetes.

Primary objective

  • To assess wound healing and granulation tissue formation when using the NPWT system

Secondary objectives

  • To investigate the pain level at dressing removal
  • To visually check exudate removal
  • To investigate the ease of use for the subject and care giver when using the NPWT system

Study Overview

Status

Completed

Conditions

Detailed Description

The investigation is designed as a prospective, open, non-controlled clinical investigation.

Wounds to be treated under this protocol should be Diabetic foot ulcers (DFUs) or post amputation wounds associated with diabetes in hospitalized subjects or subjects treated at home. One ulcer or post amputation wound per subject will be treated for a maximum duration of 4 weeks. All subjects will receive negative pressure treatment with the NPWT system, -120 mm Hg.

In total, 10-15 subjects at two sites will be enrolled provided that they fulfill all the inclusion criteria and none of the exclusion criteria and have signed and dated a written informed consent.

The subjects will be consecutively allocated to a specific subject identification code and the recruitment will be competitive.

The primary variable wound healing and granulation tissue formation will be assessed by digital planimeter, digital photography and visual estimation.

Pain level and subject/investigator convenience will be assessed by convenience surveys.

An evaluable subject is defined as a subject completing the investigation with 4 weeks of treatment, a subject healed before 4 weeks of treatment or if the investigator judge that the wound has adequately responded on NPWT before 4 weeks and that continued treatment can be made with alternative treatment.

Study Type

Interventional

Enrollment (Actual)

16

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Newcastle upon Tyne,, United Kingdom
        • Freeman Hospital
      • Norfolk,, United Kingdom
        • Norfolk & Norwich University Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (ADULT, OLDER_ADULT)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  1. Diabetic foot ulcers (DFUs) including post amputation wounds associated with diabetes suitable for Negative Pressure Wound Therapy according to the investigator's judgment
  2. 1 cm2 ≤ Wound size ≤ 200 cm2
  3. Male or female, 18 years and above
  4. Signed Informed Consent Form
  5. Subject understands the written subject Information

Exclusion Criteria:

  1. Need for frequent dressing changes, i.e.<72 hours between the changes
  2. Dry wounds
  3. Critical ischemia (for wound healing) according to investigator's judgement
  4. Malignancy in the wound and/or wound margin
  5. Target ulcer previous not successfully treated with NPWT within 48 hours
  6. Poorly controlled diabetes according to investigators judgement.
  7. Osteomyelitis which has been left untreated
  8. Infection which has been left untreated
  9. Unexplored fistula
  10. > 10% surface area necrotic tissue with eschar present after debridement
  11. High risk for bleeding complications
  12. Exposed major blood vessels, organs or nerves
  13. Current or within 3 months treatment with chemotherapy or irradiation
  14. Known hypersensitivity to the dressing material
  15. Expected technically impossible to seal the film to maintain a vacuum for treatment
  16. Expected non compliance with the Clinical Investigation Plan
  17. Pregnancy
  18. Subjects not suitable for the investigation according to the investigator's judgement
  19. Subjects previously included in this investigation
  20. Subjects included in other ongoing clinical investigation at present or during the past 30 days

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: TREATMENT
  • Allocation: NA
  • Interventional Model: SINGLE_GROUP
  • Masking: NONE

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
OTHER: NPWT system
Negative pressure wound therapy
Dressing change 3 times per week
3 dressing changes/week for maximum 4 weeks.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Mean Change in Wound Area.
Time Frame: From baseline to maximum 4 weeks
Measured by tracing of wound and measured by planimeter.
From baseline to maximum 4 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Gerard Stansby, MD, Prof., Freeman Hospital, Newcastle upon tyne

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

January 1, 2010

Primary Completion (ACTUAL)

July 1, 2010

Study Completion (ACTUAL)

July 1, 2010

Study Registration Dates

First Submitted

November 4, 2009

First Submitted That Met QC Criteria

November 10, 2009

First Posted (ESTIMATE)

November 11, 2009

Study Record Updates

Last Update Posted (ESTIMATE)

March 21, 2012

Last Update Submitted That Met QC Criteria

March 20, 2012

Last Verified

March 1, 2012

More Information

Terms related to this study

Other Study ID Numbers

  • NPWT 01

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Diabetes

Clinical Trials on NPWT System

Subscribe